Skip to product information

From Financialisation to Innovation in UK Big Pharma

Öner Tulum

Regular price €21,21
Sale price €21,21 Regular price €22,50 Sale
Tax included. Shipping calculated at checkout.

In stock

Autorius Öner Tulum
Leidimo metai 2022 m.
Puslapių skč. 75 psl.
Viršelis Minkštas viršelis
ISBN 9781009278164

From Financialisation to Innovation in UK Big Pharma

Discover the intricate relationship between innovation and financialisation in the UK pharmaceutical sector with From Financialisation to Innovation in UK Big Pharma by Öner Tulum. Published by Cambridge University Press in 2022, this insightful work spans 75 pages and delves into the dynamics of major players like AstraZeneca and GlaxoSmithKline. Tulum's analysis sheds light on how financial strategies impact the drive for innovation within these pharmaceutical giants. This title is also available as Open Access on Cambridge Core, making it accessible for those eager to explore the evolving landscape of big pharma in the UK. Perfect for students, researchers, and industry professionals alike, this book is a must-read for anyone interested in the future of healthcare and pharmaceutical innovation.

Book cover of: From Financialisation to Innovation in UK Big Pharma. By: Öner Tulum

From Financialisation to Innovation i...

Regular price €21,21
Sale price €21,21 Regular price €22,50